Annual Report

Overview

The report highlights Proteomics International's landmark exclusive licence agreement to commercialise PromarkerD in the United States and continued progress across its endometriosis, oesophageal cancer, and oxidative stress diagnostics pipeline. It also reports renewed ISO 13485 certification and ISO 17025 accreditation. During the year, the company raised $8 million through an oversubscribed placement to support production, commercialisation, and working capital.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2022-2023
Period: Ends 30 June 2023
Publication date: 22 August 2023
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services